Skin Rejuvenation Market Will Cross at a CAGR of 8.7% by the end of 2022

Aging induces various skin related problems o defects such as wrinkles, lines etc. Various medical treatments for curing these disorders are being developed. Skin rejuvenation essentially is improving the skin appearance with the help of advanced medical treatments. Global skin rejuvenation market is influenced by various aspects such as growth in medical science, innovations in various products and enhancement of technology, various manufacturers opting for advanced skin rejuvenation medication therapies, increasing prevalence of skin problems owing to aging coupled with rising consciousness and increasing disposable income of people worldwide, increasing awareness of non-invasive and minimally invasive procedures and increased investment in research and development in the skin care industry by various companies in this sector. However, the main limitation to the growth of this market is the affordability quotient as not all class of people can afford skin rejuvenation medications.

Browse Full Research Report:

https://www.persistencemarketresearch.com/market-research/skin-rejuvenation-market.asp

The extensive research report on “Skin Rejuvenation Market: Global Industry Analysis (2012-2016) and Forecast (2017-2022)” by Persistence Market Research uncovers various aspects of the global skin rejuvenation market with which a future market scenario for skin rejuvenation devices can be drawn that can assist the reader in planning expansion strategies. According to this research study, the global market for skin rejuvenation is projected to register a healthy CAGR of 8.7% throughout the period of assessment to reflect a noteworthy market value.

Request and Download Sample Report@

https://www.persistencemarketresearch.com/samples/19318

4 Key Highlights on Global Skin Rejuvenation Market

  • The global skin rejuvenation market is segmented by product type, by end user and by region.

  • By product type, the global skin rejuvenation market is dominated by IPL devices segment. This segment is a highly lucrative and estimated to be the largest segment in terms of market value and share. By the end of the assessment year, the IPL devices segment is expected to show a high value of a bit over US$ 690 Mn

  • By product type category, the laser based devices market is the fastest growing segment to reach stellar valuation. This segment is rising owing to increased use of laser in skin rejuvenation treatment procedures

  • By end user category, the dermatology clinics segment is the largest segment and is likely to lead the global skin rejuvenation market in terms of market valuation. In 2017, this segment reflected a high market share of more than 60% and is likely to continue to retain its status quo during the assessment period 2017-2022

  • By region, North America and Asia Pacific excluding Japan (APEJ) regions reflect high potential in the years to come. The North America region is expected to dominate the global market by region as it is estimated to be the largest and highly attractive for skin rejuvenation. North America skin rejuvenation market is estimated to reach a noteworthy value growing at the highest 9.4% CAGR during assessment period

  • Key Players Operating in the Global Endodontics Market – Detailed Competitive Assessment

The fact based research report on global skin rejuvenation market covers an in-depth competitive assessment which includes details like SWOT analysis, product portfolio, new developments and innovations and key financials along with company overview of key players such as Cutera Inc., Lutronic Corporation, Syneron Medical Ltd., Strata Skin Sciences, Inc., Cynosure, Inc., Lumenis Ltd., Solta Medical Inc., Lynton Lasers Ltd., EL.En. S.p.A., Sciton, Inc., Fotona d.d. and Alma Lasers, Ltd.

Buy Full Endodontics Market Report

@ https://www.persistencemarketresearch.com/checkout/19318

Advertisements

Flow Cytometry Market Will Cross US$ 63.5 Mn by the end of 2022

Flow cytometry is used to monitor microscopic particles with the help of electronic devices called flow cytometers. Flow cytometry is used in stem cell research, in the development of immunology products and vaccines and also in CD4 testing. The global flow cytometry market is influenced by various factors such as medical and technological developments in flow cytometry products, rising use of flow cytometry in clinical trials, in detection of blood cancer, in research, in launching of new reagents for critical applications such as drug discovery and diagnostics and also in development of intuitive and user-friendly software are fuelling the growth of the flow cytometry market in the forthcoming timeline. Moreover, rising prevalence of AIDS and cancer has triggered the adoption of flow cytometry technology in scientific research. This is supporting the growth of the global flow cytometry market.

Browse Full Research Report:

https://www.futuremarketinsights.com/reports/flow-cytometry-market

The analytical and extensive research report on “Flow Cytometry Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2022)” published by Future Market Insights uncovers various factors of the global market for flow cytometry which can be used to analyse and grasp opportunities in the market across regions worldwide in order to carry out expansion programs in the future. According to the market analysis in this research report, the global flow cytometry market is projected to grow at a VAGR of 7.1% during the period of assessment 2017-2022.

5 Key Highlights on the Global Flow Cytometry Market

  • The global flow cytometry market is segmented by application, end user, technology, product type and region.

  • By application, the research segment is expected to dominate the global market with respect to high market share. By the end of 2022, this segment is estimated to reach a high market valuation of around US$ 1.8 Bn growing at a high CAGR during this period. The industrial segment is projected to grow at the highest rate during the assessment period and poised to gain a high BPS by the end of 2022

  • By technology, the cell based segment is the largest segment. It is projected to grow at a CAGR of 7.2% throughout the period of forecast and is estimated to gain a very high valuation during the period of assessment

  • North America region is a highly lucrative region for the growth of the global flow cytometry market. The market in North America is soaring at a higher pace and expected to surpass other regions

  • By end user, the commercial organizations segment is expected to gain the highest BPS by end of 2022. Moreover, this segment demands increasing use of flow cytometry and is the largest and the fastest growing segment in the flow cytometry market

  • In the product type category, the reagents and consumables have gained high traction in the recent years. This segment is a high contributor of growth of the global flow cytometry market. The reagents and consumables segment is estimated to gain a high BPS and grow at a high CAGR of 7.9% throughout the period of assessment

Global Flow Cytometry Market: Competitive Landscape

The global flow cytometry market research study includes a separate section on competitive landscape in which it focuses on the key players and their in-depth analysis including company overview, SWOT analysis, developments, innovations, key financials and product portfolios. This extensive research report covers key companies such as Miltenyi Biotec GmbH, General Electric Company, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck & Co Inc., Agilent Technologies, Inc., Sysmex Corporation, Becton Dickinson and Company and Danaher Corporation.

Leadless Pacing Systems Market Will Cross US$ 63.5 Mn by the end of 2025

According to the latest market report published by Persistence Market Research titled ‘Leadless Pacing Systems Market: Global Industry Analysis (2012 – 2016) & Forecast (2017 – 2025),’ the market is poised to expand at a CAGR of 10.0% in terms of value over the forecast period (2017–2025). The overall market is anticipated to grow 2.15x in terms of value over the forecast period of 2017–2025. Certain factors such as rise in the number of eligible patients, increasing reimbursement scenario, rising disposable income, preference for new technology, growing geriatric population, rising number of cardiovascular diseases and increasing number of medical insurers is expected to support market growth over the forecast period. Revenue growth is also supported by several technological benefits of leadless pacing systems over traditional pacemaker systems. The report analyzes the leadless pacing systems market in terms of value (US$ Mn) by application type, end user and region. The report also provides information regarding market dynamics, macro-economic factors, opportunity analysis, pricing analysis, regulations, competitive landscape, regional volume analysis, current trends, market estimation and forecast, technology assessment and major deals in the leadless pacing systems market.

Browse Full Research Report:

https://www.persistencemarketresearch.com/market-research/leadless-pacing-system-market.asp

The global leadless pacing systems market is expected to exceed US$ 63.5 Mn by 2025, attesting the highest growth of the atrial fibrillation application segment, which is expected to expand at 10.1% CAGR over the forecast period. Atrial fibrillation segment will dominate the market in terms of value. In the end user segment, hospitals represent more than 85% of the market share.

In terms of value, the North America regional market holds the highest share in the global market followed by Europe. This is because of higher demand in these regions, product affordability and a favorable reimbursement scenario. Middle East & Africa represents a significant market share in the global leadless pacing systems market given the historical acceptance in the number of procedures for leadless pacing technology over traditional pacemakers. In terms of growth rate, Europe leads with a CAGR of 11.2% followed by Asia Pacific with an increasing product acceptance. Latin America is anticipated to have the least market size over the forecast period. The global market for leadless pacing systems is anticipated to expand at a significant growth rate over the forecast period providing good growth opportunities for market players.

Request and Download Sample Report@

https://www.persistencemarketresearch.com/samples/12205

Key Research Findings

  • Demand for leadless pacing systems is anticipated to remain high through 2025, registering a CAGR of 10.0% over the forecast period owing to the rising number of cardiovascular diseases and increasing pacemaker implant rate

  • Due to the technical advantages of leadless pacing systems, this product segment is anticipated to absorb significant market size in the single chamber ventricular pacing systems market

  • The higher pricing of leadless pacing systems than normal pacemakers is a major limiting factor in the leadless pacing systems market

  • There are only two companies with their products commercially approved by regulatory bodies while some other companies have their products still in the development phase. Medtronic plc. is the only company with FDA approval

  • Acquisitions, mergers, expansions, product approvals, product launches and adoption of new technologies are the key strategies adopted by manufacturers and integrators for technology transfer and to increase consumer base in different geographies

  • North America is anticipated to remain the largest consumer base for leadless pacing systems owing to a higher acceptance rate and a favorable reimbursement scenario

  • Several opportunities are available for companies to improve their product penetration such as development of dual chamber and multi chamber pacing, providing professional education & training, distribution reach etc.

Key Players

The report profiles some of the leading players operating in the global leadless pacing systems market such as Abbott Laboratories and Medtronic plc. Boston Scientific Corporation and Biotronik are still in the development phase for leadless pacing systems.

Buy Full Endodontics Market Report

@ https://www.persistencemarketresearch.com/checkout/12205

Endoscopy Equipment Market Will Cross US$33.5 bn by the end of 2022

The global endoscopy equipment market is likely to exhibit stable growth over the coming years due to a steady rise in the application of endoscopy in diverse end use diagnostic fields, the steady product development scenario in the medical devices sector, and the booming healthcare sector in developed economies. The endoscopy equipment market has remained a steady contributor to the global medical devices sector in recent years and is likely to remain relevant to the economic dynamics of the healthcare sector in the coming years due to its strong growth prospects in not just developed regions such as North America and Europe but also several emerging economies in Asia Pacific except Japan.

The global endoscopy equipment market is likely to exhibit a strong 4% CAGR in the 2017-2022 forecast period, rising from a likely 2017-end valuation of US$27.5 bn to US$33.5 bn by the end of 2022. Analysts at Transparency Market Research have attributed the growth of the endoscopy equipment market to a number of factors.

Browse Full Research Report:

https://www.transparencymarketresearch.com/endoscopy-equipment-market.html

The rapid advancement of the medical devices sector and the steady availability of funding for product enhancement is likely to remain the prime driver for the global endoscopy equipment market in the coming years. Product development has become a major strategy for players in the medical devices sector due to the steady availability of technological advances that allow for the production of better products and rising competition in the sector. The endoscopy equipment market is likely to benefit from this trend significantly in the coming years due to the rising number of players looking to carve out a significant share in the market, which has served to boost competition.

The rising prevalence of gastroenterological disorders in developed regions such as North America and Western Europe is likely to be a key driver for the global endoscopy equipment market in the coming years. Gastroenterology is the leading application of endoscopy equipment and has gained increased demand due to the growing adoption of unhealthy dietary and lifestyle choices, including the increasing preference to addictions such as tobacco and alcohol. Endoscopy plays a key role in the diagnosis of gastric problems and is the established means of diagnosis for several gastric disorders, ensuring steady growth of the endoscopy equipment market in the coming years.

The rapid growth of the healthcare sector in developing economies in Asia Pacific except Japan (APEJ) is likely to be a major driver for the global endoscopy equipment market in the coming years. The APEJ market for endoscopy equipment is likely to exhibit a strong 4.1% CAGR over the 2017-2022 forecast period, enabling a steady rise of the regional market to a valuation of more than US$7.5 bn by the end of 2022. Countries such as China, Korea, Taiwan, Indonesia, Malaysia, and India are likely to be crucial to the endoscopy equipment market in the coming years due to the growing adoption of Western lifestyles in the region and growing government support to advancement of the healthcare and medical devices sector.

Leading players in the increasingly competitive global endoscopy equipment market include Arthrex Inc., Stryker Corporation, B. Braun Melsungen AG, Boston Scientific Corporation, Olympus Corporation, Cook Medical Inc., Karl Storz GmbH & Co. KG, Smith & Nephew Plc, Fujifilm Holdings Corporation, and Medtronic Plc.

 

Spinal Fusion Market Pegged to Reach US$ 12,561.9 Mn by the end of 2027

Future Market Insights (FMI) delivers key insights on the global spinal fusion market in its upcoming report titled “Spinal Fusion Market: Global Industry Analysis 2012–2016 and Opportunity Assessment 2017 – 2027.” In terms of revenue, the global spinal fusion market is projected to register a CAGR of 5.4% over the forecast period, owing to various factors, regarding which FMI offers detailed insights and forecasts in this report. A key trend witnessed in the global spinal fusion market is the rise in the development of minimising load due to increasing adverse reactions. Furthermore, the growing importance of developing advanced products among big players to enhance their product portfolio is another key trend in the global spinal fusion market.

Market Segmentation and Forecast

The global spinal fusion market is segmented based on product type, procedure type, end user and region. Based on product type, the market is segmented into interbody cages, pedicle screws and rods, and spinal fusion plates. Interbody cages is predicted to be the leading product type segment in the global spinal fusion market over the forecast period. Attenuated interbody cages segment will represent major revenue share of the global spinal fusion market in 2017.  By procedure, the global spinal fusion market is segmented into posterolateral fusion and interbody fusion. Interbody fusion is the leading segment in the global spinal fusion market over the forecast period. By end user, the global spinal fusion market is segmented into hospitals, speciality clinics and ambulatory surgical centres. Hospitals is the leading segment in the global spinal fusion market over the forecast period. Demand for spinal fusion is expected to be the highest in ambulatory surgical centres, which is expected to register a CAGR of 6.6 % over the forecast period.

This report assesses the trends that are driving the growth of each segment at the global as well as regional level, and offers potential takeaways that could prove substantially useful to manufacturers looking to enter the market. North America is expected to gain popularity over the forecast period, driven by increasing prevalence of spinal injuries across the region. The North America regional market is projected to dominate the global spinal fusion market, accounting for a maximum revenue share of the global market by 2017 end. The markets in North America, Western Europe, and Asia Pacific are collectively expected to account for around 68.6% of the global spinal fusion market value share by 2017 end. Revenue from the market in APEJ is estimated to expand at a CAGR of 8.9% over the forecast period.

Key Players

Some of the leading market players covered in the report include Zimmer Biomet Holdings. Inc., K2M, Inc., MicroPort Scientific Corporation, Medtronic Plc., Johnson and Johnson (DePuy Synthes), Stryker Corporation, Integra Lifesciences Holdings Corp, Orthofix Holdings, Inc., Shandong Weigao Group Medical Polymer Company Limited, Bonovo Orthopedics, Inc., Suzhou Gemmed Medical Instrument Co. Ltd, NuVasive, Inc., B. Braun Melsungen AG, Globus Medical Inc., RTI Surgical, Inc., Expanding Orthopedics Inc., Vallum Corporation, ChoiceSpine, LP, Life Spine, Inc, and Precision Spine, Inc. In this report, we have discussed the individual strategies followed by these companies regarding bringing improvements in their products, creating new manufacturing facilities, market consolidation and advanced R&D initiatives. The report concludes with key takeaways for players already present in the market and new players planning to enter the market.

Browse Full Research Report Herehttps://www.futuremarketinsights.com/reports/global-spinal-fusion-market

Soft Tissue Allografts Market Pegged to Touch US$6.2 bn by the end of 2025

A fresh study by Transparency Market Research (TMR) notifies that the global soft tissue allografts market was dominated by Allergan, plc. in 2016, and the company is poised to sustain its strong market position in the near future via its impressive product portfolio, geographical presence, and frequent strategic acquisitions. For example, Allergan completed the acquisition of Acelity L.P. Inc.’s LifeCell Corporation for US$2.9 bn in February 2017. This move will help the company to make a foray into regenerative medicine and add to its high-quality and durable portfolio. Besides the commercial products of LifeCell, Allergan will also acquire the New Jersey Company’s innovative manufacturing capabilities and its research and development operations.

The TMR report also identifies some of the other prominent companies currently operating in the global soft tissue allografts market, namely Zimmer Biomet, Lattice Biologics Ltd., AlonSource Group, AlloSource, MiMedix Group, Inc., CONMED Corporation, Organogenesis Inc., RTI Surgical, Inc., Integra LifeSciences Corporation, Globus Medical Inc, Straumann Holding AG, Osiris Therapeutics, Inc., Arthrex, Inc., Xtant Medical, Alliqua BioMedical, Inc, C. R. Bard, Inc (Davol Inc.), B. Braun Melsungen AG, and Bone Bank Allograft.

As per the projections of the TMR report, the demand in the global soft tissue allografts market will swell at a healthy CAGR of 6.3% during the forecast period of 2017 to 2025. The report estimates the market for soft tissue allografts, across the world, to be worth US$6.2 bn by the end of 2025, substantially up from its evaluated valuation of US$3.6 bn in 2016. Based on

product type, collagen allograft was the most profitable segment, owing to its applications in aesthetics surgery, wound care, and orthopedic surgeries. Application-wise, wound care category held major market share in 2016, followed by dentistry. Geographically, North America currently serves the maximum demand in the global soft tissue allografts market.

For well over a century, soft tissue allografts have been considered a successful procedure, and each year, nearly 1 million allografts are transplanted in the U.S. alone. Soft tissue allografts are substitute tissues that are used to reconstruct deficient ligaments, spinal surgery, torn menisci, and osteochondral defects during knee surgery. Soft tissue allografts undergo a three-stage safety screening process of donor screening, laboratory testing, and tissue preparation. Soft tissue allografts can be made up of bone, tendons, cartilage, skin, heart valves, and veins used for transplant in different types of surgeries.

In the recent past, the usage of soft tissue allografts has grown due to increase in the number of cases in dental implants and orthopedic surgery. Escalating geriatric population, growing demand for new technological advancement for production of new tissues by tissue banks, and rise in demand of soft tissue allografts among athletes of numerous sports and other walks of life are some of the key factors driving the demand in the global soft tissue allografts market. Increase in ACL surgery, escalating incidences of diabetes foot ulcer, growing popularity of cosmetic surgery to treat facial disorders with new technologies are some of the other factors favoring the global soft tissue allografts market.

While high cost of procedures continues to challenge the market for soft tissue allografts, especially in the emerging economies, the lack of defined reimbursement policies is also obstructing the market expansion. In addition to that, complications pertaining to increased risk of infection and immune response such as disruption of infected anastomotic rigid line with a rupture, microbial infection, and bowel formation is hindering the proper prosperity of the global soft tissue allografts market.

Browse Full Research Report: https://www.transparencymarketresearch.com/soft-tissue-allografts-market.html

Surgical Tables Market to Rise at 3.9% CAGR during 2017-2022

The global surgical tables market has made rapid progress in the last few years. The primary driver responsible for this has been the rapid growth of the healthcare sector in developed regions, as this has provided the surgical tables market with a growing demand channel. This is likely to remain the key driver for the global surgical tables market in the coming years due to the strong growth prospects of the healthcare sector. The growing importance of surgical tables in surgical procedures is likely to propel the global surgical tables market, as this will drive significant product development in the coming years, leading to growing demand.

According to Transparency Market Research, the global surgical tables market was valued at US$837.1 mn in 2017 and is likely to rise to US$1,014.3 mn by 2022 at a steady 3.9% CAGR. The growth of the market is supported by the favorable economic and regulatory environment in key regional segments and is thus likely to continue unhindered in the coming years.

Developed countries in North America and Europe are likely to remain the leading contributors to the global surgical tables market in the coming years. The North America market for surgical tables was valued at US$246.9 mn in 2017. Driven by the favorable prospects of the healthcare industry in North America, the surgical tables market in the region is likely to rise to a valuation of US$301.5 mn by 2022. This represents a strong 4.1% CAGR through the 2017-2022 forecast period, indicative of the likely dominance of North America in the global surgical tables market in the coming years.

The Europe market accounted for a significant 27.8% share in the global surgical tables market in 2017 due to the presence of strong government support to the development of an indigenous healthcare sector. A number of leading medical device companies are based in Europe due to the presence of longstanding traditions of workmanship, which is likely to drive the surgical tables market in Europe in the coming years. Despite an expected fall in its global market share over the 2017-2022 forecast period, Europe is likely to remain relevant to global market dynamics in spite of the growing prominence of Asia Pacific

The vast scope of unmet demand in emerging regions such as Asia Pacific is likely to remain a key driver for the global surgical tables market in the coming year. Underdeveloped countries in Latin America and the Middle East are also likely to become major contributors to the surgical tables market in the coming years. The Asia Pacific except Japan market for surgical tables is expected to be valued at US$244 mn by 2022, exhibiting a 4.1% CAGR in the 2017-2022 forecast period. Japan accounted for 9.6% of the global surgical tables market in 2017 and is likely to remain a steady contributor to the global surgical tables market.

The Middle East and Africa could also play an important role in the global surgical tables market’s development in the coming years. Prospering economies in the Middle East have become major players in the global healthcare sector in recent years due to the growing economic clout of these countries. The widespread lack of advanced medical infrastructure in Africa could become a key driver for the surgical tables market if the healthcare sector in the region managed to get aid from more prosperous economies. The Middle East and Africa accounted for 4% of the global surgical tables market in 2017.

The global surgical tables market is likely to remain fragmented in the coming years due to the presence of a disbanded opportunity across the world. Leading companies in the market include AMTAI Medical Equipment, Inc., Allengers Medical Systems Limited, C-RAD AB, Getinge AB, Skytron Inc., STERIS, Elekta AB, Span America Medical System Inc., and Stryker Corporation.

Browse Full Research Report: https://www.transparencymarketresearch.com/surgical-tables-market.html

Endodontics Market to Grow at 5.2% CAGR during the year 2017-2022

Endodontics is associated with the dentistry segment. It involves several therapies to protect the human teeth from infections and injuries caused to the dental pulp. Generally, it is concerned with morphology, pathology as well as physiology of dental pulp and the periradicular tissues. Endodontics is important during carrying out root canal procedure in order to reduce the inflammation and to end infection. Modernization has touched the field of endodontics as well with the introduction of magnifying lenses and surgical microscopy. These sophistications ensure increased accuracy of the treatment and in examination of the structure of the periradicular tissue along with the dental pulp.

Browse Full Research Report: https://www.persistencemarketresearch.com/market-research/endodontics-market.asp

An extensive research report on “Endodontics Market: Global Industry Analysis (2012-2016) and Forecasts (2017-2022)” by Persistence Market Research uncovers various market facts that can be used as guidelines by the reader to achieve stability in the changing dynamics of the global market and accordingly plan future expansions on a worldwide basis. According to the comprehensive research study, the global endodontics market is projected to witness a steady 5.2% CAGR during the period of assessment to reach a significant valuation by the end of 2022.

Request and Download Sample Report@

https://www.persistencemarketresearch.com/samples/19129

3 Key Highlights on Global Endodontics Market

  • The global endodontics market is segmented by product type, by end user and by region with a view to get a glimpse of various endodontic products across key regions worldwide.

  • By end user, the dental clinics segment is expected to be highly lucrative segment. Dental clinics are potential end users for endodontic products. This segment is the largest segment with respect to market share and poised to grow at a high CAGR of 5.5% throughout the period of assessment.

  • By product type, the consumables segment is anticipated to hold high potential. The adoption of endodontic consumables has witnessed growth since past years to make this segment a highly lucrative one. It is estimated to reflect a high market share and is poised to grow at a high CAGR of 3% throughout the period of assessment.

  • By region, Europe and Asia Pacific excluding Japan (APEJ) show high potential. Europe region is the largest region with respect to market share as well as growth rate. It presents high opportunities to endodontic players. The Europe endodontic market is anticipated to soar at a high CAGR of 6.0% throughout the period of assessment. Asia Pacific excluding Japan (APEJ) region is poised to grow at a significant CAGR during 2017-2022.

  • The exhaustive research report on global Nano healthcare technology for medical equipment market has detailed analysis on the various key players involved in this market. Key companies such as Thermo Fisher Scientific Inc., Stryker Corporation, Smith & Nephew Plc., PerkinElmer, Inc., Merck KGaA, GE Global Research, Ferro Corp, AstraZeneca Plc., Abbott Laboratories and 3M Company are profiled in this research study.

Key Players Operating in the Global Endodontics Market – Detailed Competitive Assessment

The insightful research report on global endodontics market includes profiles of important players involved in the endodontics market. Key financials, company overview, developments and innovations and product portfolio of key players such as Coltene Holding AG, Mani, Inc., Peter Brasseler Holdings, L.P., FKG Dentaire S.A., Septodont Ltd., Ultradent Products Inc., Ivoclar Vivadent AG, Danaher Corporation and Dentsply Sirona Inc., are included in this research study.

Buy Full Endodontics Market Report

@ https://www.persistencemarketresearch.com/checkout/19129

Nano Healthcare Technology for Medical Equipment Market to Value US$ 9.2 Bn by 2022

Nanotechnology is expected to potentially transform healthcare industry, especially in the medical devices field in the coming years. The global market for Nano healthcare technology for medical equipment has been witnessing a rising growth path since 2012. Till 2016, this market has seen gradual growth, however, during the 2017-2022 period this market is expected to witness a robust growth rate.

There are many factors which drive this meteoric growth of the entire market. The rise in aging population, rising prevalence of cardiovascular diseases, increasing incidence of diseases linked with ear, bone, and other internal organs of the body, medical advancements due to adoption of improved technology and increase in the expenditure on research in the Nanotechnology field coupled with rising government support have spurred the development of the global market for Nano healthcare technology for medical equipment. However, certain pulling aspects such as higher initial costs and time consuming approvals for product launches are posing challenges to the advancement of the market from a global standpoint.

Browse Full Research Report:

https://www.persistencemarketresearch.com/market-research/nano-healthcare-technology-for-medical-equipment-market.asp

An exhaustive research report on “Nano Healthcare Technology for Medical Equipment Market: Global Industry Analysis (2012-2016) and Forecast (2017-2022)” skilfully crafted by Persistence Market Research focuses on various facets of the global market based on which guidelines can be slated with a view to achieve an edge over the competition as well as stability even in the unstable market conditions. According to this research report, the global market Nano healthcare technology for medical equipment is expected to expand at a robust CAGR of 9.6% during the period of forecast 2017-2022.

Request and Download Sample Report@

https://www.persistencemarketresearch.com/samples/18898

4 Key Insights on Global Nano Healthcare Technology for Medical Equipment Market

  • North America region is expected to witness high market share by 2022 end. This region lead the global market in 2016 and this trend is poised to continue over the forecast period. North America region is the largest and highly lucrative region for the growth of the global market for Nano healthcare technology for medical equipment and is expected to register the highest CAGR of 10% during the period of forecast.

  • Asia-Pacific excluding Japan (APEJ) region is expected to show high potential after North America and is the second fastest growing region. Nano healthcare technology for medical equipment in APEJ market is expected to expand at a high 9.8% CAGR during 20170-2022. Europe, in terms of value is the second largest region owing to development in the healthcare system combined with increasing number medical device manufacturers adopting Nanotechnology in medical equipment and various programs for development of nanotechnology started by government.

  • Implantable material and biochips segments by product type show promising growth in the coming years. Biochips segment is expected to rise at a high CAGR of 9.6% during the period of forecast. The implantable materials segment show higher market share comparatively. The active implantable devices segment is the fastest growing segment dominating the global market by product type.

  • Therapeutic applications segment by application type is expected to grow at a higher pace to register a CAGR of 9.9% during the period of forecast. In 2017, this segment portrayed higher market share and is highly likely to cement its dominance during the forecast period in terms of market share and valuation

The exhaustive research report on global Nano healthcare technology for medical equipment market has detailed analysis on the various key players involved in this market. Key companies such as Thermo Fisher Scientific Inc., Stryker Corporation, Smith & Nephew Plc., PerkinElmer, Inc., Merck KGaA, GE Global Research, Ferro Corp, AstraZeneca Plc., Abbott Laboratories and 3M Company are profiled in this research study.

Buy Full Nano healthcare technology for medical equipment Market Report@ https://www.persistencemarketresearch.com/checkout/1889

Drywall & Building Plasters Market Going to Reach US$ 65,004.8 Mn by 2025

Persistence Market Research in its latest report projects that the global drywall & building plasters market will expand at a CAGR of 5.4% during the forecast period (2017–2025) to reach a valuation of US$ 65,004.8 Mn. Lately, preference for drywall has increased to a significant level as compared with other construction materials such as cement concrete owing to its superior characteristics and ease of application, hence making it a suitable alternative. In 2016, global drywall & building plaster market stood at around US$ 40,624.6 Mn. The report titled “Drywall & Building Plaster Market Global Industry Trend Analysis 2012–2016 and Forecast, 2017–2025” projects that close to 14,202 million square meters of drywall is likely to be sold towards the end of 2025.

Drywall & building plasters find widespread applications in new building constructions as well as in upgrade, maintenance and repair work of old residential & nonresidential structures. This, in turn, is anticipated to drive their sales in the years to come. Moreover, economic growth in certain countries is expected to fuel investments in residential & commercial infrastructure, which is expected to play a major role in boosting the market’s growth. Growth in demand for drywall & building plasters is directly linked with proceedings in the construction industry.

Key Insights of the Report Include:

By product type, building plasters will continue to account for a higher value share of the market than drywall throughout the assessment period. On the other hand, drywall is expected to register a faster CAGR in terms of value. By 2017-end, the drywall segment is estimated to account for around 42.3% share of the overall market.

Application of drywall & building plaster in residential and hotels & restaurant construction is expected to remain robust in 2017 and beyond. These application segments are expected to account for a large percentage of the global market revenue.

Download Report Table of Content, Figures, and Tables @http://www.persistencemarketresearch.com/market-research/drywall-building-plasters-market/toc

The market in Asia Pacific is estimated to remain dominant over 2025, owing to several massive ongoing and upcoming construction projects in countries such as China and India. In addition, the region has been exhibiting a higher demand for drywall & building plasters than other regions, on account of its high growth rate & market size of the building construction market. Meanwhile, North America will continue to be the second largest market for drywall & building plaster over the forecast period. In Europe, factors such as increasing awareness about the product advantages and growing requirement of maintenance & repair activities are expected to fuel the demand for drywall & building plasters.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/3360

Some of the leading companies operating in the global market for drywall & building plaster include Knauf Gips KG, Compagnie de Saint-Gobain S.A., Etex S.A., USG Corporation, Fermacell, Gyptec Iberica, Georgia-Pacific, National Gypsum Properties, LLC, USG Boral Building Products, PABCO Building Products, LLC, American Gypsum Company LLC, ROCKWOOL International A/S, Continental Building Products, LafargeHolcim, Winstone Wallboards Limited, China National Building Material Company Limited, Kingspan Group plc., Yoshino Gypsum Co., Ltd., Supress Products, LLC, Lime Green Products Ltd.

Browse Complete Report @ http://www.persistencemarketresearch.com/market-research/drywall-building-plasters-market.asp